English (United States)|Italiano (Italia)
English (United States) | Italiano (Italia)
Press review

February 28, 2019 - ITFPHARMA

ITF Pharma has been named an honoree for the 2018 Patient Impact Award, presented by Life Sciences Pennsylvania, for the successful launch and approval of TIGLUTIK


November 30, 2018 - Adnkronos

The project: make the first move take care of your bones. The "awareness" initiative on osteoporosis is supported by Abiogen and Italfarmaco and will interest 11 scientific societies involved in the study of metabolic bone diseases.


September 06, 2018 - ITFPHARMA

ITF PHARMA announces FDA approval of TIGLUTIK™ (riluzole) oral suspension for the tratment of amyotrophic lateral sclerosis (ALS)


September 06, 2018 - ABOUTPHARMA ONLINE

Sla, Fda approva riluzolo di Italfarmaco


June 28, 2017 - Il Giorno Milano

Malattia rara. Un accordo da 5,6 milioni per la ricerca


March 27, 2017 - Il Sole24 Ore

Più calcio e vitamina D per ridurre le fratture da osteoporosi e far risparmiare il Ssn


March 25, 2015 - Pharmakronos

L'accordo Chemi-Teva dà i suoi frutti


February 25, 2015 - Pharmastar

Distrofia di Duchenne, bene in fase II il givinostat, farmaco di ricerca Italfarmaco


March 01, 2014 - Espansione

L'industria farmaceutica in un mondo che cambia - Tavola Rotonda. Il settore farmaceutico, tra attualità e prospettive.


December 13, 2013 - Helsinn.com

Helsinn and Italfarmaco reinforce their alliance through the grant of rights to phase-III ghrelin receptor agonist Anamorelin in Italy